230 related articles for article (PubMed ID: 19243309)
1. Identification of small-molecule inhibitors of the JIP-JNK interaction.
Chen T; Kablaoui N; Little J; Timofeevski S; Tschantz WR; Chen P; Feng J; Charlton M; Stanton R; Bauer P
Biochem J; 2009 May; 420(2):283-94. PubMed ID: 19243309
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide.
Ngoei KR; Catimel B; Church N; Lio DS; Dogovski C; Perugini MA; Watt PM; Cheng HC; Ng DC; Bogoyevitch MA
Biochem J; 2011 Mar; 434(3):399-413. PubMed ID: 21162712
[TBL] [Abstract][Full Text] [Related]
3. Reverse two-hybrid screening identifies residues of JNK required for interaction with the kinase interaction motif of JNK-interacting protein-1.
Barr RK; Hopkins RM; Watt PM; Bogoyevitch MA
J Biol Chem; 2004 Oct; 279(41):43178-89. PubMed ID: 15271995
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
5. Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1.
Ember B; Kamenecka T; LoGrasso P
Biochemistry; 2008 Mar; 47(10):3076-84. PubMed ID: 18269248
[TBL] [Abstract][Full Text] [Related]
6. An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue.
Jaeschke A; Czech MP; Davis RJ
Genes Dev; 2004 Aug; 18(16):1976-80. PubMed ID: 15314024
[TBL] [Abstract][Full Text] [Related]
7. The JIP family of MAPK scaffold proteins.
Whitmarsh AJ
Biochem Soc Trans; 2006 Nov; 34(Pt 5):828-32. PubMed ID: 17052208
[TBL] [Abstract][Full Text] [Related]
8. The human stress-activated protein kinase-interacting 1 gene encodes JNK-binding proteins.
Schroder W; Bushell G; Sculley T
Cell Signal; 2005 Jun; 17(6):761-7. PubMed ID: 15722200
[TBL] [Abstract][Full Text] [Related]
9. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
[TBL] [Abstract][Full Text] [Related]
10. Sab (SH3BP5), a novel mitochondria-localized JNK-interacting protein.
Wiltshire C; Gillespie DA; May GH
Biochem Soc Trans; 2004 Dec; 32(Pt 6):1075-7. PubMed ID: 15506969
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site.
Stebbins JL; De SK; Machleidt T; Becattini B; Vazquez J; Kuntzen C; Chen LH; Cellitti JF; Riel-Mehan M; Emdadi A; Solinas G; Karin M; Pellecchia M
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16809-13. PubMed ID: 18922779
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-dependent dimerization and subcellular localization of islet-brain 1/c-Jun N-terminal kinase-interacting protein 1.
Borsello T; Centeno C; Riederer IM; Haefliger JA; Riederer BM
J Neurosci Res; 2007 Dec; 85(16):3632-41. PubMed ID: 17663463
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of M3/6 (DUSP8) signaling complexes in response to arsenite-induced oxidative stress.
Oehrl W; Cotsiki M; Panayotou G
Cell Signal; 2013 Feb; 25(2):429-38. PubMed ID: 23159405
[TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK.
Matsuda S; Yasukawa T; Homma Y; Ito Y; Niikura T; Hiraki T; Hirai S; Ohno S; Kita Y; Kawasumi M; Kouyama K; Yamamoto T; Kyriakis JM; Nishimoto I
J Neurosci; 2001 Sep; 21(17):6597-607. PubMed ID: 11517249
[TBL] [Abstract][Full Text] [Related]
15. Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases.
Ho DT; Bardwell AJ; Grewal S; Iverson C; Bardwell L
J Biol Chem; 2006 May; 281(19):13169-13179. PubMed ID: 16533805
[TBL] [Abstract][Full Text] [Related]
16. JNK: bridging the insulin signaling and inflammatory pathway.
Liu G; Rondinone CM
Curr Opin Investig Drugs; 2005 Oct; 6(10):979-87. PubMed ID: 16259218
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic promise of JNK ATP-noncompetitive inhibitors.
Bogoyevitch MA
Trends Mol Med; 2005 May; 11(5):232-9. PubMed ID: 15882611
[TBL] [Abstract][Full Text] [Related]
18. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
[TBL] [Abstract][Full Text] [Related]
19. c-Jun N-terminal kinase pathways in diabetes.
Yang R; Trevillyan JM
Int J Biochem Cell Biol; 2008; 40(12):2702-6. PubMed ID: 18678273
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors.
Zhao H; Serby MD; Xin Z; Szczepankiewicz BG; Liu M; Kosogof C; Liu B; Nelson LT; Johnson EF; Wang S; Pederson T; Gum RJ; Clampit JE; Haasch DL; Abad-Zapatero C; Fry EH; Rondinone C; Trevillyan JM; Sham HL; Liu G
J Med Chem; 2006 Jul; 49(15):4455-8. PubMed ID: 16854050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
